The epidermal growth factor receptor (EGFR) is frequentlymutatedin human cancer, most notably non-small-cell lung cancer and glioblastoma.While many frequently occurring EGFR mutations are known to conferconstitutive EGFR activation, the situation is less clear for rarelydetected variants. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.